-
If you purchased shares of Anadys Pharmaceuticals (NASDAQ: ANDS) prior to the announcement and currently hold those shares, you have certain options and you should contact the Shareholders Foundation, Inc.
-
To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Investigation Overview
San Diego, Oct. 17, 2011 (Shareholders Foundation) -- The announcement that Anadys Pharmaceuticals agreed to be acquired by Roche for $3.70 per NASDAQ:ANDS shares prompted an investigation on behalf of investors of Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS) concerning whether the offer to acquire Anadys Pharmaceuticals, Inc. and the buyout process are unfair to investors of Anadys Ph...
You must register (for free) or login to view the entire investigation.
